NO803935L - Fremgangsmaate ved fremstilling av nye 2-acylaminomethyl-1,4-benzodiazepiner - Google Patents

Fremgangsmaate ved fremstilling av nye 2-acylaminomethyl-1,4-benzodiazepiner

Info

Publication number
NO803935L
NO803935L NO803935A NO803935A NO803935L NO 803935 L NO803935 L NO 803935L NO 803935 A NO803935 A NO 803935A NO 803935 A NO803935 A NO 803935A NO 803935 L NO803935 L NO 803935L
Authority
NO
Norway
Prior art keywords
acylaminomethyl
benzodiazepines
procedure
preparation
new
Prior art date
Application number
NO803935A
Other languages
English (en)
Other versions
NO154883B (no
NO154883C (no
Inventor
Horst Zeugner
Hans Liepmann
Wolfgang Milkowski
Dietmar Roemer
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of NO803935L publication Critical patent/NO803935L/no
Publication of NO154883B publication Critical patent/NO154883B/no
Publication of NO154883C publication Critical patent/NO154883C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO803935A 1979-12-24 1980-12-23 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-acylaminomethyl-1,4-benzodiazepiner. NO154883C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792952279 DE2952279A1 (de) 1979-12-24 1979-12-24 Neue 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
NO803935L true NO803935L (no) 1981-06-25
NO154883B NO154883B (no) 1986-09-29
NO154883C NO154883C (no) 1987-01-07

Family

ID=6089628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803935A NO154883C (no) 1979-12-24 1980-12-23 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-acylaminomethyl-1,4-benzodiazepiner.

Country Status (21)

Country Link
US (2) US4325957A (no)
EP (1) EP0031080B1 (no)
JP (1) JPS5699477A (no)
AU (1) AU542701B2 (no)
CA (1) CA1169425A (no)
DD (2) DD200274A5 (no)
DE (3) DE2952279A1 (no)
DK (1) DK548080A (no)
ES (2) ES8201142A1 (no)
FI (1) FI68050C (no)
GR (1) GR73080B (no)
HU (1) HU185398B (no)
IE (1) IE50580B1 (no)
IL (1) IL61692A (no)
NO (1) NO154883C (no)
NZ (1) NZ195872A (no)
PH (1) PH17189A (no)
PT (2) PT72279B (no)
SU (1) SU1253430A3 (no)
YU (1) YU324780A (no)
ZA (1) ZA807704B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3021107A1 (de) * 1980-06-04 1981-12-17 Hoechst Ag, 6000 Frankfurt Carbamoyloxyamino-1,4-benzodiazepine, verfahren zu irer herstellung und diese enthaltende arzneimittel
DE3048264A1 (de) * 1980-12-20 1982-09-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3124013A1 (de) * 1981-06-19 1982-12-30 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3151597A1 (de) * 1981-12-28 1983-07-07 Kali-Chemie Pharma Gmbh, 3000 Hannover (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4724237A (en) * 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
EP0170024A3 (en) * 1984-06-26 1990-01-31 Merck & Co. Inc. Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions
US4684646A (en) * 1984-06-26 1987-08-04 Merck & Co., Inc. 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists
JPH01314666A (ja) * 1988-06-15 1989-12-19 Kayaba Ind Co Ltd パワーステアリング装置の操舵力制御装置
GB8823042D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
US5380721A (en) * 1990-09-10 1995-01-10 Sterling Winthrop Inc. Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
JPH0546660U (ja) * 1991-12-03 1993-06-22 カヤバ工業株式会社 パワーステアリング装置
CN1384867A (zh) 1999-08-27 2002-12-11 宝洁公司 稳定性提高的配制组分、使用该组分的组合物和洗衣方法
BR0014153A (pt) * 1999-08-27 2002-05-07 Procter & Gamble Componentes de intensificação de branqueamento, composições e métodos de lavagem
US6818607B1 (en) 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
BR0013610A (pt) * 1999-08-27 2002-07-16 Procter & Gamble Componentes de formulções de ação rápida,composições e métodos para lavar roupa empregando os mesmos
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
US7169744B2 (en) * 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
KR100877824B1 (ko) 2005-11-11 2009-01-12 한국생명공학연구원 E2epf ucp-vhl 상호작용 및 그 용도
CN113149914A (zh) * 2021-01-15 2021-07-23 福安药业集团重庆礼邦药物开发有限公司 一种咪达***中间体脱氟杂质的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681340A (en) * 1968-02-12 1972-08-01 Herman Robert Rodriguez 1,3-benzodiazepines
US3738999A (en) * 1970-05-28 1973-06-12 Squibb & Sons Inc 2,3,4,5-tetrahydro-2-phenyl-1,4-benzothiazepine, hydrochloride
DE2353187A1 (de) * 1973-05-02 1974-11-14 Kali Chemie Ag Neue benzodiazepinderivate
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
US3925358A (en) * 1973-07-27 1975-12-09 Hoffmann La Roche 1-Lower alkyl-2-substituted-1,4-benzodiazepines
US3947475A (en) * 1975-04-28 1976-03-30 Stauffer Chemical Company 5-Furoyl-2,2,4-trimethyl-1,4-dihydro-1H-1,5-benzodiazepine as an anti-inflammatory agent
US4087421A (en) * 1976-04-19 1978-05-02 American Cyanamid Company Substituted benzodiazepines and method of use

Also Published As

Publication number Publication date
DD200274A5 (de) 1983-04-06
DK548080A (da) 1981-07-23
EP0031080B1 (de) 1983-09-21
FI68050C (fi) 1985-07-10
EP0031080A1 (de) 1981-07-01
US4325957A (en) 1982-04-20
DE3070798D1 (en) 1985-07-25
NO154883B (no) 1986-09-29
ES498071A0 (es) 1981-12-01
PT72278B (en) 1981-11-06
IL61692A (en) 1984-08-31
NZ195872A (en) 1983-06-17
CA1169425A (en) 1984-06-19
IE50580B1 (en) 1986-05-14
DE3064983D1 (en) 1983-10-27
US4382030A (en) 1983-05-03
AU6566480A (en) 1981-07-02
SU1253430A3 (ru) 1986-08-23
PH17189A (en) 1984-06-14
NO154883C (no) 1987-01-07
PT72279A (en) 1981-01-01
IL61692A0 (en) 1981-01-30
FI803988L (fi) 1981-06-25
AU542701B2 (en) 1985-03-07
IE802531L (en) 1981-06-24
ES8201142A1 (es) 1981-12-01
FI68050B (fi) 1985-03-29
GR73080B (no) 1984-01-31
HU185398B (en) 1985-01-28
DE2952279A1 (de) 1981-06-25
PT72278A (en) 1981-01-01
ZA807704B (en) 1981-11-25
YU324780A (en) 1983-12-31
DD155988A5 (de) 1982-07-21
JPS6332072B2 (no) 1988-06-28
JPS5699477A (en) 1981-08-10
ES8201143A1 (es) 1981-12-01
ES498072A0 (es) 1981-12-01
PT72279B (en) 1981-11-06

Similar Documents

Publication Publication Date Title
NO803935L (no) Fremgangsmaate ved fremstilling av nye 2-acylaminomethyl-1,4-benzodiazepiner
NO794327L (no) Fremgangsmaate ved fremstilling av nye peptidylargininaldehyd-derivater.
NO154919C (no) Analogifremgangsmaate ved fremstilling av nye kinazolinderivater.
NO801015L (no) Fremgangsmaate ved fremstilling av nye piperidinderivater
NO793349L (no) Fremgangsmaate ved fremstilling av nye 5h-2,3-benzodiazepinderivater.
NO800650L (no) Fremgangsmaate ved fremstilling av nye indolderivater
NO801014L (no) Fremgangsmaate for fremstilling av nye piperidinderivater
NO803851L (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO792760L (no) Fremgangsmaate ved fremstilling av nye nafthydrinderivater
NO792823L (no) Fremgangsmaate ved fremstilling av nye arginiamidderivater
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO801855L (no) Fremgangsmaate ved fremstilling av nye enkafalinderivater
NO800338L (no) Fremgangsmaate ved fremstilling av nye 4-(nafthylmethyl)piperidinderivater.
NO803247L (no) R fremgangsmaate ved fremstilling av nye pyridothienotriazine
NO802402L (no) R fremgangsmaate ved fremstilling av nye halovincamonderivate
NO833521L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk virksomme vinylthioacetamido-oxacefalosporinderivater
NO803044L (no) Fremgangsmaate ved fremstilling av nye derivater av 1,2,4-oxadiazolin-5-on
NO152898C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive substituerte acetofenoner.
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO802403L (no) Fremgangsmaate ved fremstilling av nye 10-halogen-e-homo-eburnanderivater.
NO158422C (no) Analogifremgangsmaate ved fremstilling av nye oksadiazolopyrimidin-derivater.
NO166365C (no) Nye 7-acyl-3-halogenindoler som er anvendbare som mellomprodukter ved fremstilling av 7-acylindolin-2-oner.
NO154884C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutiske aktive 4-iazo-androstan-dioner.
NO154634C (no) Fremgangsmaate ved fremstilling av delvis nye benzimidazolderivater.